semaglutide 0.3 mg Active ingredient in Ozempic, Wegovy shows early promise for treating alcohol use disorder among those with obesity: Study New weight loss medications carry

According to the Ozempic SmPC, semaglutide should be discontinued if pancreatitis is suspected and not restarted if pancreatitis is confirmed

Between December 2024 and February 2025, there were 143 new lawsuits filed related to Wegovy and other GLP-1 drugs

Y.KarbowskiM.SmithC

Everything flows from there

Take Ashley Dunham, for instance - she lost 70 pounds in just 5.5 months and saw her menstrual cycles return to normal

over-the-counter omega-3 supplements are not recommended by NICE for cardiovascular disease prevention The key distinction is that GLP-1 receptor agonists are not prescribed primarily for lipid modification